The largest database of trusted experimental protocols

37 protocols using puromycin

1

Establishing Stable Cell Lines for EK and RIG-I Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
To establish stable 293T clones expressing EK or EK-X2, we transfected the cells with a pcDNA vector (Thermo Fisher) expressing the EK or EK-X2 cDNA together with a hygromycin-resistance gene. After selection with 150 μg/ml hygromycin B (Thermo Fisher), several independent clones expressing EK or EK-X2 were isolated and analyzed.
To establish stable A549 cells, we used a lentiviral vector (the pLVX series, TaKaRa) to express small hairpin RNAs (shRNAs) under the control of the U6 promoter (the target sequences knocked down are listed in Table 3), together with a puromycin-resistance gene or blasticidin-resistance gene under the control of the PGK promoter. The recombinant lentiviruses were constructed by simultaneously transfecting 293T cells with the pLVX vector and lentiviral plasmids expressing Gag/Pol, Rev, and VSVG (Naldini et al., 1996 (link)). After selection with 1.3 μg/ml puromycin (Nacalai Tesque, Inc., Kyoto, Japan), the puromycin-resistant A549 cells expressing RIG-I-targeting shRNA were pooled, and stored for analysis and subsequent experiments. The sh-RIG-I A549 cells were then infected with recombinant lentiviruses expressing shRNAs targeting different sites in the EK mRNA (sh-EK#1, sh-EK#2, and control shRNA), and selected with 180 μg/ml blasticidin S (Wako Pure Chemical Industries, Ltd, Osaka, Japan). The blasticidin-resistant cells were pooled and analyzed.
+ Open protocol
+ Expand
2

CRISPR-Cas9 Mediated Gene Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid DNA (1 μg) was transfected into suspended DU145, PC3 or 22Rv1 cells (1 × 105 cells) using the NENO system (Invitrogen) (voltage; 1150, width; 30, pulse number; 2). Transfected DU145 cells were cultured with 1.0 μg/mL puromycin (Nacalai Tesque) or 2 mM G418 (Nacalai Tesque), while transfected PC3 and 22Rv1 cells were respectively cultured with 4.0 μg/mL and 0.5 μg/mL puromycin. Single colonies were selected and individually cultured. pX330 including the target gRNA sequence (1 μg) and pPGK-puro (0.5 μg) were transfected into suspended DU145 cells (1 × 105) using the NENO system; the DU145 cells were then cultured with 1.0 μg/mL puromycin for 1 week and then cultured without puromycin. Single colonies were selected and individually cultured. Genotypes were identified by PCR, which was performed using Q5 high-fidelity DNA polymerase (New England Biolabs Inc. (NEB), MA, USA).
+ Open protocol
+ Expand
3

Cell Culture and Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T and HEK293 cells were maintained in low glucose Dulbecco’s modified Eagle’s medium (Nacalai Tesque) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 100 units/mL penicillin and 100 μg/mL streptomycin (Nacalai Tesque). Cells were transfected with plasmid DNAs using polyethylenimine ‘MAX’ (Polysciences, Warrington, PA, USA) and then selected with Puromycin (Nacalai Tesque) for pCAGIPuro vectors to establish stable cell lines.
+ Open protocol
+ Expand
4

Culturing Human Pancreatic Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased the human pancreatic cancer cell lines (PK-1, PK-8, KLM-1, Panc-1 and MIAPaca2) from RIKEN BioResouce Research Center (RIKEN BRC, Ibaraki, Japan) and another human pancreatic cancer cell line (BxPC-3) and Plat-A amphotropic retrovirus packaging cells from American Type Culture Collection (ATCC, Manassas, VA, USA). We maintained PK-1, PK-8, KLM-1, Panc-1 and BxPC-3 in RPMI-1640 (Nacalai Tesque) supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA), 100 U/ml penicillin (Life Technologies, Carlsbad, CA, USA) and 100 μg/ml streptomycin (Life Technologies) at 37°C in a humidified 5% CO2 incubator. We maintained MIAPaca2 and Plat-A in DMEM (Nacalai Tesque) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. In Plat-A culture, 1 μg/ml of puromycin (Nacalai Tesque) and 10 μg/ml of blasticidin (Funakoshi, Tokyo, Japan) were added.
+ Open protocol
+ Expand
5

Generation of Knockdown Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate CHD7, BRN2, and SOX21 knockdown cells, we transduced human NE cells with lentiviruses expressing shRNA targeting CHD7, BRN2, and SOX21, respectively. All shRNA vectors were purchased from Sigma (for details, see Supplemental Table S6). For rescue experiments, the cDNAs of human SOX21 (GenBank: NM_007084.2) and BRN2 (GenBank: NM_005604.3) were cloned into the pENTR-D-TOPO vector (Invitrogen). Using LR reaction (Invitrogen), the cDNAs were inserted into the CSIV-CBh-RfA-IRES2-HygR construct. Lentiviral packaging plasmids pCAG-HIVgp and pCMV-VSV-G-RSV-Rev were cotransfected into HEK293T cells with Gene Juice (Merck) for virus production. Lentiviral supernatant was collected 48 h after transfection and supplemented with 4 µg/mL polybrene, filtered through a 0.45-µm filter, and used to infect human NE cells. At 48 h after infection, the cells were selected with either 1 µg/mL puromycin (Nacalai Tesque) or a combination of 1 µg/mL puromycin and 80 µg/mL hygromycin (Sigma).
+ Open protocol
+ Expand
6

Puromycin Incorporation Assay for Measuring Ongoing Protein Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
puromycin incorporation assay (alternatively called SUnSET assay) was performed according to Schmidt et al. (57 (link)). HeLa cells were pretreated with or without 10 or 20 μM of TMPyP4 or 1 or 20 μM of CHX for 20 min followed by additional treatment in the presence or the absence of 10 μg/ml puromycin (Nakarai Tesque; 14861-71) for 10 min for pulse labeling of ongoing translation. Cells were washed once with PBS and then served for WB.
+ Open protocol
+ Expand
7

Lentivirus-Mediated Overexpression of CEP164 in Panc1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentivirus supernatant was produced by co-transfection of pLVX-IRES-Puro [Empty Vector (EV)] or pLVX-3Flag-CEP164-IRES-Puro (CEP164) with Δ8.9, pcRev, and VSVG plasmids (gift from M. Hagiwara) into Lenti-X 293T cells using PEI Max. The virus supernatant was harvested 72 h post-transfection and concentrated using Lenti-X Concentrator (Clonetech). Panc1 cells were incubated with virus in the presence of 5 μg/ml polybrene (Nacalai Tesque) for 72 h. The infected Panc1 cells were subsequently cultured in medium with 5 μg/ml puromycin (Nacalai Tesque) for 8 days. Established cells (WT + EV, Cep164-1 + EV, and Cep164-1 + Cep164) were cultured in medium with 3 μg/ml puromycin.
+ Open protocol
+ Expand
8

Tau P301L Overexpression in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (Nacalai Tesque) supplemented with 10% (v/v) fetal bovine serum (Hyclone, Logan UT, USA), and kept at 37 °C under a humidified atmosphere of 5% CO2/95% air. Cells were seeded at 1 × 105 cells/well in a 24-well plate. At 24 h after plating, the cells were transfected with the pIRESpuro3 vector containing human tau with the P301L mutation using Lipofectamine 3000 reagent (Thermo Fisher Scientific). After a 24-h incubation period, the cells were transferred to a 6-cm culture dish, and stable cell lines were selected with 1 µg/mL puromycin (Nacalai Tesque) for 12 days. Single cells from resistant colonies were transferred into the wells of 96-well plates.
+ Open protocol
+ Expand
9

Plasmid Construction and Stable Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
pΔBM d2EGFP was constructed as previously described (46 (link)). It contains a BSR gene driven by SRαpromoter, the d2EGFP gene driven by a CMV promoter, and a DHFR IR (Ori β; 4634 bp) that contains a sequence showing in vitro MAR activity (15 (link)). The plasmids were cloned into Escherichia coli DH5α cells. Plasmid DNA was purified using the PureLink HiPure plasmid midiprep kit (Invitrogen).
COLO 320DM cells were transfected using GenePORTER2 Transfection Reagent (Genlantis Co), whereas CHO DG44 cells were transfected using Lipofectamine 2000 Reagent (ThermoFisher Scientific Co) according to the manufacturers' recommended protocols. Stable transformants were selected on blasticidin (Funakoshi) or puromycin (Nacalai Tesque).
+ Open protocol
+ Expand
10

CRISPR/Cas9 Knockdown Workflow in MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The targeted gRNA oligos were introduced into the pX330 vector (Addgene, Cambridge, MA, USA). Then 1.2 μg each pX330 plasmid DNA with target gRNA sequence and 0.6 μg pPGKpuro (Addgene) were transfected into MDA‐MB‐231 cells (2 × 105 cells) using NEON (Invitrogen) electroporation, and the transfected cells were cultured for 2 days with 1.0 μg/mL puromycin (Nacalai Tesque) in medium for selection. Living cells were diluted in 10‐cm dishes for colony formation. Single colonies were picked and cultured for proliferation. The DNA of each colony was abstracted using the DNeasy Blood & Tissue Kit (Qiagen), and the genomic region containing the CRISPR/Cas9 target site gene was amplified by PCR. The PCR products were purified using QIAquick Gel Extraction Kit (Qiagen) following the manufacturer's protocol and cloned into the pCR‐Blunt II‐TOPO vector (Invitrogen). A number of colonies were selected, and the sequences were analyzed on a 3100 Genetic Analyzer (Applied Biosystems).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!